These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
337 related items for PubMed ID: 11708878
21. Resistance of prostate cancer cells to soluble TNF-related apoptosis-inducing ligand (TRAIL/Apo2L) can be overcome by doxorubicin or adenoviral delivery of full-length TRAIL. Voelkel-Johnson C, King DL, Norris JS. Cancer Gene Ther; 2002 Feb; 9(2):164-72. PubMed ID: 11857034 [Abstract] [Full Text] [Related]
22. Cell-type-specific and regulatable transgenesis in the adult brain: adenovirus-encoded combined transcriptional targeting and inducible transgene expression. Smith-Arica JR, Morelli AE, Larregina AT, Smith J, Lowenstein PR, Castro MG. Mol Ther; 2000 Dec; 2(6):579-87. PubMed ID: 11124058 [Abstract] [Full Text] [Related]
28. Targeted expression of green fluorescent protein/tumor necrosis factor-related apoptosis-inducing ligand fusion protein from human telomerase reverse transcriptase promoter elicits antitumor activity without toxic effects on primary human hepatocytes. Lin T, Gu J, Zhang L, Huang X, Stephens LC, Curley SA, Fang B. Cancer Res; 2002 Jul 01; 62(13):3620-5. PubMed ID: 12097263 [Abstract] [Full Text] [Related]
29. In vivo transgene expression using an adenoviral tetracycline-regulated system with neuron-specific enolase promoter. Bhattacharjee AK, Ueyama T, Kondoh T, Hayashi S, Abouelfetouh A, Sakai N, Saito N, Kohmura E. Biochem Biophys Res Commun; 2004 May 14; 317(4):1144-8. PubMed ID: 15094388 [Abstract] [Full Text] [Related]
34. Adenoviral vector containing wild-type p16 suppresses prostate cancer growth and prolongs survival by inducing cell senescence. Steiner MS, Zhang Y, Farooq F, Lerner J, Wang Y, Lu Y. Cancer Gene Ther; 2000 Mar 10; 7(3):360-72. PubMed ID: 10766342 [Abstract] [Full Text] [Related]
35. Highly suppressible expression of single-chain interleukin-12 by doxycycline following adenoviral infection with a single-vector Tet-regulatory system. Block A, Puls F, Müller J, Milasinovic D, Igelmann D, Schäfer P, Kupfermann N, Schmoldt A, Ameis D, Greten H. J Gene Med; 2003 Mar 10; 5(3):190-200. PubMed ID: 12666185 [Abstract] [Full Text] [Related]
36. Controlled gene expression with a reverse tetracycline-regulated retroviral vector (RTRV) system. Watsuji T, Okamoto Y, Emi N, Katsuoka Y, Hagiwara M. Biochem Biophys Res Commun; 1997 May 29; 234(3):769-73. PubMed ID: 9175791 [Abstract] [Full Text] [Related]